CB

Clare Burrows

CDH secures buyout of HK-listed firm

The China-focused private equity firm intends to take a majority stake in New Focus Auto Holdings, acquiring $97.4m worth of its stocks and bonds.

2 min read · 19 September 2013

Report: CIC appoints new chairman

After months of speculation as to who will head the Chinese sovereign wealth fund, CIC is said to have selected Xuedong Ding to fill the role.

2 min read · 19 September 2013

AustralianSuper: Consolidation likely to benefit PE

The on-going consolidation of Australia’s LPs could result in increased allocations to alternative assets, according to AustralianSuper's GM of investments.

2 min read · 19 September 2013

Pioneer seals NZ$40m from NZ super fund

Pioneer Capital is the third domestic manager with a focus on SMEs expanding globally to receive a commitment from the New Zealand Superannuation Fund.

3 min read · 19 September 2013

Anacacia exits Rafferty’s in £42m trade sale

The Australian country manager has sold its investment in the baby-food manufacturer to UK-listed PZ Cussons, just a month after Australian regulators blocked a bid from Heinz & Co.

3 min read · 19 September 2013

China's cross border deals on the rise

China’s outbound M&A continues to grow – despite the reservations in some quarters overseas about Chinese buyers, writes Clare Burrows

3 min read · 19 September 2013

India unlocks insurers for PE investment

Insurance companies in India, representing a potential $10 billion in capital, have been given the green light to invest in alternative investment funds.

2 min read · 19 September 2013

PwC: China PE indicators fall broadly

As deals, exits and fundraising falter in China, private equity firms are gradually finding more buyout opportunities, according to figures from PricewaterhouseCoopers.

3 min read · 19 September 2013

L Capital Asia blows through target

The private equity firm has made a first and final close on its $950m hard cap six months after launch, raising what is possibly the region's largest sector fund ever.

2 min read · 19 September 2013

Hony Capital to privatise US-listed pharma company

The Beijing-based firm joins a consortium of investors taking private Chinese pharmaceutical company Simcere in a deal worth close to $500m.

2 min read · 19 September 2013

Showing 671 to 680 of 867 results
1…6769…87